85 related articles for article (PubMed ID: 15049844)
1. The conformation and movement of Na channel inactivation gate peptide in linker between domain III and IV during inactivation by NMR spectroscopy and molecular modeling study.
Lou BS; Lin TH; Lo CZ
J Pept Res; 2004 Mar; 63(3):313-23. PubMed ID: 15049844
[TBL] [Abstract][Full Text] [Related]
2. Locations of local anesthetic dibucaine in model membranes and the interaction between dibucaine and a Na+ channel inactivation gate peptide as studied by 2H- and 1H-NMR spectroscopies.
Kuroda Y; Ogawa M; Nasu H; Terashima M; Kasahara M; Kiyama Y; Wakita M; Fujiwara Y; Fujii N; Nakagawa T
Biophys J; 1996 Sep; 71(3):1191-207. PubMed ID: 8873993
[TBL] [Abstract][Full Text] [Related]
3. Solution structure of the cytoplasmic linker between domain III-S6 and domain IV-S1 (III-IV linker) of the rat brain sodium channel in SDS micelles.
Miyamoto K; Nakagawa T; Kuroda Y
Biopolymers; 2001 Oct; 59(5):380-93. PubMed ID: 11514941
[TBL] [Abstract][Full Text] [Related]
4. Interaction of local anesthetics with a peptide encompassing the IV/S4-S5 linker of the Na+ channel.
Fraceto LF; Oyama S; Nakaie CR; Spisni A; de Paula E; Pertinhez TA
Biophys Chem; 2006 Aug; 123(1):29-39. PubMed ID: 16687202
[TBL] [Abstract][Full Text] [Related]
5. 1H-NMR and circular dichroism spectroscopic studies on changes in secondary structures of the sodium channel inactivation gate peptides as caused by the pentapeptide KIFMK.
Kuroda Y; Maeda Y; Miyamoto K; Tanaka K; Kanaori K; Otaka A; Fujii N; Nakagawa T
Biophys J; 1999 Sep; 77(3):1363-73. PubMed ID: 10465748
[TBL] [Abstract][Full Text] [Related]
6. The interactions of phenytoin and its binding site in DI-S6 segment of Na+ channel voltage-gated peptide by NMR spectroscopy and molecular modeling study.
Lou BS; Lin TH; Lo CZ
J Pept Res; 2005 Jul; 66(1):27-38. PubMed ID: 15946193
[TBL] [Abstract][Full Text] [Related]
7. Outward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channels.
Sheets MF; Hanck DA
J Physiol; 2007 Jul; 582(Pt 1):317-34. PubMed ID: 17510181
[TBL] [Abstract][Full Text] [Related]
8. Molecular modeling of local anesthetic drug binding by voltage-gated sodium channels.
Lipkind GM; Fozzard HA
Mol Pharmacol; 2005 Dec; 68(6):1611-22. PubMed ID: 16174788
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of gating and drug block of sodium channels.
Catterall WA
Novartis Found Symp; 2002; 241():206-18; discussion 218-32. PubMed ID: 11771647
[TBL] [Abstract][Full Text] [Related]
10. Access and binding of local anesthetics in the closed sodium channel.
Bruhova I; Tikhonov DB; Zhorov BS
Mol Pharmacol; 2008 Oct; 74(4):1033-45. PubMed ID: 18653802
[TBL] [Abstract][Full Text] [Related]
11. Probing the non-covalent binding interaction of the Na+ channel inactivation gate peptide in a linker between domain III and IV with 5,5-diphenyhydantoin in electrospray ion trap tandem mass spectrometry.
Lou BS; Chen YC; Wu HF
Rapid Commun Mass Spectrom; 2007; 21(23):3795-802. PubMed ID: 17973233
[TBL] [Abstract][Full Text] [Related]
12. Modeling of benzocaine analog interactions with the D4S6 segment of NaV4.1 voltage-gated sodium channels.
Godwin SA; Cox JR; Wright SN
Biophys Chem; 2005 Jan; 113(1):1-7. PubMed ID: 15617805
[TBL] [Abstract][Full Text] [Related]
13. NH2-terminal inactivation peptide binding to C-type-inactivated Kv channels.
Kurata HT; Wang Z; Fedida D
J Gen Physiol; 2004 May; 123(5):505-20. PubMed ID: 15078918
[TBL] [Abstract][Full Text] [Related]
14. Voltage-gated Na+ channel ligands and ATP: relative molecular similarity and implications for channel function.
Williams WR
J Pharm Pharmacol; 2006 Sep; 58(9):1235-41. PubMed ID: 16945182
[TBL] [Abstract][Full Text] [Related]
15. Na channel inactivation from open and closed states.
Armstrong CM
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17991-6. PubMed ID: 17101981
[TBL] [Abstract][Full Text] [Related]
16. Structural studies of synthetic peptides dissected from the voltage-gated sodium channel.
Doak DG; Mulvey D; Kawaguchi K; Villalain J; Campbell ID
J Mol Biol; 1996 May; 258(4):672-87. PubMed ID: 8637001
[TBL] [Abstract][Full Text] [Related]
17. Suppression of insulin signalling by a synthetic peptide KIFMK suggests the cytoplasmic linker between DIII-S6 and DIV-S1 as a local anaesthetic binding site on the sodium channel.
Hirose M; Kuroda Y; Sawa S; Nakagawa T; Hirata M; Sakaguchi M; Tanaka Y
Br J Pharmacol; 2004 May; 142(1):222-8. PubMed ID: 15037518
[TBL] [Abstract][Full Text] [Related]
18. [Molecular mechanisms underlying gating activity of voltage dependent ion channels].
Lu GW
Sheng Li Ke Xue Jin Zhan; 1997 Oct; 28(4):306-10. PubMed ID: 11038679
[TBL] [Abstract][Full Text] [Related]
19. Solution structure of the sodium channel inactivation gate.
Rohl CA; Boeckman FA; Baker C; Scheuer T; Catterall WA; Klevit RE
Biochemistry; 1999 Jan; 38(3):855-61. PubMed ID: 9893979
[TBL] [Abstract][Full Text] [Related]
20. Insight toward epithelial Na+ channel mechanism revealed by the acid-sensing ion channel 1 structure.
Stockand JD; Staruschenko A; Pochynyuk O; Booth RE; Silverthorn DU
IUBMB Life; 2008 Sep; 60(9):620-8. PubMed ID: 18459164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
